Perfil clínico de los pacientes octogenarios con fibrilación auricular no valvular atendidos en una consulta general de cardiología

Feinberg, 1995, Prevalence, age distribution and gender of patients with atrial fibrillation., Arch Intern Med., 155, 469, 10.1001/archinte.155.5.469 Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke., 22, 983, 10.1161/01.STR.22.8.983 1994, Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II Study, Lancet., 343, 687 Mant, 2007, Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, Lancet., 370, 493, 10.1016/S0140-6736(07)61233-1 Fuster, 2001, ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation, Eur Heart J., 22, 1852 Fuster, 2006, Circulation., 114, e257, 10.1161/CIRCULATIONAHA.106.177292 Heras, 1999, Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología, Rev Esp Cardiol., 52, 801, 10.1016/S0300-8932(99)75009-8 Almendral, 2001, Guías de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas, Rev Esp Cardiol, 54, 307, 10.1016/S0300-8932(01)76313-0 Ezekowitz, 2004, The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation, Mayo Clin Proc., 79, 904, 10.4065/79.7.904 Friberg, 2006, Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study), Eur Heart J., 27, 1954, 10.1093/eurheartj/ehl146 Simpson, 2005, Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care, Stroke., 36, 1771, 10.1161/01.STR.0000173398.99163.9e Hylek, 2006, Translating the results of randomised trials into clinical practice: the challenge of warfarin candidacy among hospitalised elderly patients with atrial fi brillation, Stroke., 37, 1075, 10.1161/01.STR.0000209239.71702.ce Burton, 2006, The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study, Br J Gen Pract., 56, 697 Ruiz Ortiz, 2003, Un protocolo prospectivo permite incrementar la utilización de anticoagulación oral en pacientes con fibrilación auricular crónica no valvular, Rev Esp Cardiol., 56, 971, 10.1157/13052385 Ruiz Ortiz, 2006, Anticoagulación oral en la fibrilación auricular no valvular: ¿son efectivas y seguras las recomendaciones científicas en la práctica clínica diaria?, Rev Esp Cardiol., 59, 688, 10.1157/13091370 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA., 285, 2864, 10.1001/jama.285.22.2864 Ruiz Ortiz, 2008, Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS2 en una población mediterránea, Rev Esp Cardiol., 61, 29, 10.1157/13114954 Ruiz Ortiz, 2010, Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS2 score on outcome, Cardiology., 115, 200, 10.1159/000284450 Ruiz Ortiz, 2005, Oral anticoagulation in patients aged 75 years or older with chronic nonvalvular atrial fibrillation: effectiveness and safety in daily clinical practice, Heart., 91, 1225, 10.1136/hrt.2004.050831 Rash, 2007, A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO), Age Ageing., 236, 151, 10.1093/ageing/afl129